Thailand and Bayer Discuss THB153 Million Clinical Research Investment

On 6 November, Thailand’s Ministry of Public Health signed a cooperation memorandum with Bayer to strengthen clinical research, access to innovative medicines and AI-supported retinal disease screening. Bayer proposed an initial clinical research investment of approximately THB153 million. The screening initiative aims to expand coverage from two million to four million people, supporting earlier detection of eye diseases. The partnership creates opportunities in clinical research, medical technology, pharmaceutical services and healthcare innovation. HPC can support healthcare market research, investment assessments and medical-sector partnership development.